We look forward to serving you.


CURRENT CLINICAL TRIALS





Multiple Sclerosis (MS)

If you have relapsing-remitting multiple sclerosis (RRMS) and are between the ages of 18-65, you may want to join this study evaluating an investigational drug that may help reduce your relapses. Please read more in our MS Trial Flyer.

Qualified volunteers will receive study-related medical evaluations and study drug at no cost. Compensation for time and travel may also be provided. Your participation is voluntary and you may leave the study at any time.

Multiple Sclerosis

ECommunity research is conducting an observational study to evaluate long-term safety in patients with MS. You may qualify if you:

  • Newly treated with Tecfidera
  • Treated with another approved disease-modifying therapy (Avonex, Rebif, Betaseron, Copaxone, Extavia, Gilenya)

 

Parkinson’s Disease

ECommunity research is conducting a study to evaluate an FDA approved drug for patients with Parkinson’s Disease and Neurogenic Hypotension. Please read more in our Flyer .  You may be eligible if you:

  • at least 18 or older and able to walk at least 10 meters
  • if you have a clinical diagnosis of symptomatic orthostatic hypotension
  • do not have a diagnosis of Hypertension (high blood pressure) that requires treatment with medication to lower your blood pressure

 

Parkinson’s Disease and Dyskinesia

ECommunity research is conducting a study to evaluate an experimental drug for patients with Parkinson’s Disease and Dyskinesia. Please read more in our Flyer. You may be eligible if you:

  • You are between 30-85 years old
  • You have Parkinson’s disease
  • If you currently take Levodopa
  • If you experience Dyskinesia (involuntary twisting and turning) that you find troublesome

 

 

 

  • Contact Us